BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 36749840)

  • 1. A discriminative event-based model for subtype diagnosis of sporadic Creutzfeldt-Jakob disease using brain MRI.
    Venkatraghavan V; Pascuzzo R; Bron EE; Moscatelli M; Grisoli M; Pickens A; Cohen ML; Schonberger LB; Gambetti P; Appleby BS; Klein S; Bizzi A
    Alzheimers Dement; 2023 Aug; 19(8):3261-3271. PubMed ID: 36749840
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prion propagation estimated from brain diffusion MRI is subtype dependent in sporadic Creutzfeldt-Jakob disease.
    Pascuzzo R; Oxtoby NP; Young AL; Blevins J; Castelli G; Garbarino S; Cohen ML; Schonberger LB; Gambetti P; Appleby BS; Alexander DC; Bizzi A
    Acta Neuropathol; 2020 Aug; 140(2):169-181. PubMed ID: 32535770
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sporadic Creutzfeldt-Jakob disease VM1: phenotypic and molecular characterization of a novel subtype of human prion disease.
    Gelpi E; Baiardi S; Nos C; Dellavalle S; Aldecoa I; Ruiz-Garcia R; Ispierto L; Escudero D; Casado V; Barranco E; Boltes A; Molina-Porcel L; Bargalló N; Rossi M; Mammana A; Tiple D; Vaianella L; Stoegmann E; Simonitsch-Klupp I; Kasprian G; Klotz S; Höftberger R; Budka H; Kovacs GG; Ferrer I; Capellari S; Sanchez-Valle R; Parchi P
    Acta Neuropathol Commun; 2022 Aug; 10(1):114. PubMed ID: 35978418
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MRI lesion profiles in sporadic Creutzfeldt-Jakob disease.
    Meissner B; Kallenberg K; Sanchez-Juan P; Collie D; Summers DM; Almonti S; Collins SJ; Smith P; Cras P; Jansen GH; Brandel JP; Coulthart MB; Roberts H; Van Everbroeck B; Galanaud D; Mellina V; Will RG; Zerr I
    Neurology; 2009 Jun; 72(23):1994-2001. PubMed ID: 19506221
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Subtype Diagnosis of Sporadic Creutzfeldt-Jakob Disease with Diffusion Magnetic Resonance Imaging.
    Bizzi A; Pascuzzo R; Blevins J; Moscatelli MEM; Grisoli M; Lodi R; Doniselli FM; Castelli G; Cohen ML; Stamm A; Schonberger LB; Appleby BS; Gambetti P
    Ann Neurol; 2021 Mar; 89(3):560-572. PubMed ID: 33274461
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Defining the phenotypic spectrum of sporadic Creutzfeldt-Jakob disease MV2K: the kuru plaque type.
    Baiardi S; Mammana A; Dellavalle S; Rossi M; Redaelli V; Colaizzo E; Di Fede G; Ladogana A; Capellari S; Parchi P
    Brain; 2023 Aug; 146(8):3289-3300. PubMed ID: 36883639
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selective vulnerability to atrophy in sporadic Creutzfeldt-Jakob disease.
    Younes K; Rojas JC; Wolf A; Sheng-Yang GM; Paoletti M; Toller G; Caverzasi E; Luisa Mandelli M; Illán-Gala I; Kramer JH; Cobigo Y; Miller BL; Rosen HJ; Geschwind MD
    Ann Clin Transl Neurol; 2021 Jun; 8(6):1183-1199. PubMed ID: 33949799
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prions from Sporadic Creutzfeldt-Jakob Disease Patients Propagate as Strain Mixtures.
    Cassard H; Huor A; Espinosa JC; Douet JY; Lugan S; Aron N; Vilette D; Delisle MB; Marín-Moreno A; Peran P; Beringue V; Torres JM; Ironside JW; Andreoletti O
    mBio; 2020 Jun; 11(3):. PubMed ID: 32546613
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An autopsied case of MV2K + C-type sporadic Creutzfeldt-Jakob disease presenting with widespread cerebral cortical involvement and Kuru plaques.
    Iwasaki Y; Saito Y; Aiba I; Kobayashi A; Mimuro M; Kitamoto T; Yoshida M
    Neuropathology; 2017 Jun; 37(3):241-248. PubMed ID: 28568896
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mathematical models for the diffusion magnetic resonance signal abnormality in patients with prion diseases.
    Figini M; Alexander DC; Redaelli V; Fasano F; Grisoli M; Baselli G; Gambetti P; Tagliavini F; Bizzi A
    Neuroimage Clin; 2015; 7():142-54. PubMed ID: 25610776
    [TBL] [Abstract][Full Text] [Related]  

  • 11. EEG - Imaging Evolution of the MV2 Subtype of Sporadic Creutzfeldt-Jakob Disease During the two-Year Course of the Disease.
    Theodora A; Styliani-Aggeliki S; Panagiotis I; Theodoros S; Marina B; Nikolaos G
    Clin EEG Neurosci; 2023 Mar; 54(2):164-167. PubMed ID: 35585697
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnostic value of diffusion-weighted brain magnetic resonance imaging in patients with sporadic Creutzfeldt-Jakob disease: a systematic review and meta-analysis.
    Park HY; Kim M; Suh CH; Kim SY; Shim WH; Kim SJ
    Eur Radiol; 2021 Dec; 31(12):9073-9085. PubMed ID: 33982159
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MM2-type sporadic Creutzfeldt-Jakob disease: new diagnostic criteria for MM2-cortical type.
    Hamaguchi T; Sanjo N; Ae R; Nakamura Y; Sakai K; Takao M; Murayama S; Iwasaki Y; Satoh K; Murai H; Harada M; Tsukamoto T; Mizusawa H; Yamada M
    J Neurol Neurosurg Psychiatry; 2020 Nov; 91(11):1158-1165. PubMed ID: 32839349
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An autopsied case of MM1 + MM2-cortical with thalamic-type sporadic Creutzfeldt-Jakob disease presenting with hyperintensities on diffusion-weighted MRI before clinical onset.
    Iwasaki Y; Mori K; Ito M; Mimuro M; Kitamoto T; Yoshida M
    Neuropathology; 2017 Feb; 37(1):78-85. PubMed ID: 27436355
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Default Mode Network quantitative diffusion and resting-state functional magnetic resonance imaging correlates in sporadic Creutzfeldt-Jakob disease.
    Paoletti M; Caverzasi E; Mandelli ML; Brown JA; Henry RG; Miller BL; Rosen HJ; DeArmond SJ; Bastianello S; Seeley WW; Geschwind MD
    Hum Brain Mapp; 2022 Sep; 43(13):4158-4173. PubMed ID: 35662331
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evolution of Diffusion-Weighted Magnetic Resonance Imaging Signal Abnormality in Sporadic Creutzfeldt-Jakob Disease, With Histopathological Correlation.
    Eisenmenger L; Porter MC; Carswell CJ; Thompson A; Mead S; Rudge P; Collinge J; Brandner S; Jäger HR; Hyare H
    JAMA Neurol; 2016 Jan; 73(1):76-84. PubMed ID: 26569479
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlating diffusion-weighted MRI intensity with type 2 pathology in mixed MM-type sporadic Creutzfeldt-Jakob disease.
    Ikeda T; Iwasaki Y; Sakurai K; Akagi A; Riku Y; Mimuro M; Miyahara H; Kitamoto T; Matsukawa N; Yoshida M
    J Neurol Sci; 2020 Jan; 408():116515. PubMed ID: 31675505
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Co-occurrence of types 1 and 2 PrP(res) in sporadic Creutzfeldt-Jakob disease MM1.
    Kobayashi A; Mizukoshi K; Iwasaki Y; Miyata H; Yoshida Y; Kitamoto T
    Am J Pathol; 2011 Mar; 178(3):1309-15. PubMed ID: 21356381
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PrP mRNA and protein expression in brain and PrP(c) in CSF in Creutzfeldt-Jakob disease MM1 and VV2.
    Llorens F; Ansoleaga B; Garcia-Esparcia P; Zafar S; Grau-Rivera O; López-González I; Blanco R; Carmona M; Yagüe J; Nos C; Del Río JA; Gelpí E; Zerr I; Ferrer I
    Prion; 2013; 7(5):383-93. PubMed ID: 24047819
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regional pattern of microgliosis in sporadic Creutzfeldt-Jakob disease in relation to phenotypic variants and disease progression.
    Franceschini A; Strammiello R; Capellari S; Giese A; Parchi P
    Neuropathol Appl Neurobiol; 2018 Oct; 44(6):574-589. PubMed ID: 29345730
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.